Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$537M |
| 2 |
Goldman Sachs
GS
|
+$200M |
| 3 |
Intuit
INTU
|
+$149M |
| 4 |
ExxonMobil
XOM
|
+$149M |
| 5 |
Salesforce
CRM
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$172M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$169M |
| 3 |
Amazon
AMZN
|
+$158M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$155M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.54% |
| 2 | Financials | 12.61% |
| 3 | Industrials | 10.64% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Healthcare | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOUS
1376
DELISTED
Anywhere Real Estate
HOUS
| $792K | ﹤0.01% |
45,180
+33,525
| +288% | +$591K |
|
|
KNBE
1377
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $791K | ﹤0.01% |
+36,022
| New | +$899K |
|
|
TRUE
1378
DELISTED
TrueCar
TRUE
| $790K | ﹤0.01% |
+189,940
| New | +$881K |
|
1379
Cable One
CABO
$149M
| $789K | ﹤0.01% |
+435
| New | +$852K |
|
1380
CALL
Humana
HUM
$46.8B
| $778K | ﹤0.01% |
2,000
+300
| +18% | +$127K |
|
|
MDRX
1381
DELISTED
Veradigm Inc. Common Stock
MDRX
| $757K | ﹤0.01% |
56,597
+1,084
| +2% | +$17.5K |
|
1382
CALL
Colgate-Palmolive
CL
$72.8B
| $756K | ﹤0.01% |
+10,000
| New | +$794K |
|
|
NEWR
1383
DELISTED
New Relic, Inc.
NEWR
| $753K | ﹤0.01% |
+10,495
| New | +$775K |
|
|
SPWR
1384
DELISTED
SunPower Corporation Common Stock
SPWR
| $752K | ﹤0.01% |
+33,138
| New | +$775K |
|
1385
CALL
ASML
ASML
$670B
| $745K | ﹤0.01% |
1,000
-500
| -33% | -$393K |
|
|
AERI
1386
CALL
DELISTED
Aerie Pharmaceuticals
AERI
| $741K | ﹤0.01% |
+65,000
| New | +$950K |
|
1387
Arcosa
ACA
$7.13B
| $740K | ﹤0.01% |
+14,755
| New | +$765K |
|
1388
Texas Pacific Land
TPL
$25.7B
| $740K | ﹤0.01% |
5,508
-6,543
| -54% | -$1.02M |
|
1389
Factset
FDS
$10.5B
| $737K | ﹤0.01% |
1,866
-6,353
| -77% | -$2.31M |
|
|
TELL
1390
DELISTED
Tellurian Inc.
TELL
| $732K | ﹤0.01% |
+187,319
| New | +$640K |
|
|
CPAR
1391
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $731K | ﹤0.01% |
+75,000
| New | +$728K |
|
1392
Novanta
NOVT
$5.28B
| $716K | ﹤0.01% |
+4,636
| New | +$674K |
|
1393
Kulicke & Soffa
KLIC
$4.42B
| $715K | ﹤0.01% |
+12,262
| New | +$764K |
|
1394
TTEC Holdings
TTEC
$69M
| $711K | ﹤0.01% |
7,604
+1,187
| +18% | +$121K |
|
1395
CALL
Weyerhaeuser
WY
$17.6B
| $711K | ﹤0.01% |
+20,000
| New | +$701K |
|
1396
CALL
Micron Technology
MU
$1.05T
| $710K | ﹤0.01% |
10,000
-9,000
| -47% | -$676K |
|
|
LHDX
1397
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $710K | ﹤0.01% |
93,439
+57,224
| +158% | +$483K |
|
1398
CALL
Citigroup
C
$224B
| $702K | ﹤0.01% |
+10,000
| New | +$699K |
|
1399
National Grid
NGG
$81.6B
| $701K | ﹤0.01% |
+13,289
| New | +$762K |
|
|
PDCO
1400
DELISTED
Patterson Companies, Inc.
PDCO
| $701K | ﹤0.01% |
23,273
-666,735
| -97% | -$20.2M |
|
Similar funds
Dmitry Balyasny's Q3 2021 Portfolio in Review
As of Q3 2021, Dmitry Balyasny held 2,691 positions worth $24B, up 14% from $21.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $2.75B of net new capital in Q3 2021, opening 770 new positions and adding to 420 existing holdings. Its largest new stake was Salesforce: 556,949 shares worth $151M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Fortive, an estimated $138M trimmed.
- Dmitry Balyasny's largest Q3 2021 buy was Salesforce: 556,949 shares worth $151M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $537M increase.
- Dmitry Balyasny's biggest Q3 2021 reduction was Fortive, cutting an estimated $138M.
- Dmitry Balyasny fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $172M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $24B portfolio in Q3 2021.
- Dmitry Balyasny opened 770 new positions and closed 817 in Q3 2021.
- Dmitry Balyasny's portfolio value rose 14% quarter-over-quarter to $24B.
Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.